Latest Breaking News On - Alexion soliris - Page 1 : comparemela.com

Pearce IP BioBlast w/e 17 May 2024

Pearce IP BioBlast w/e 17 May 2024
lexology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lexology.com Daily Mail and Mail on Sunday newspapers.

West virginiaUnited statesSaudi arabiaSouth koreaUnited kingdomSamsung bioepisAlexion solirisKlinge pharma gmbGlenmark lirafitPharma klingeMylan bioconSamsung bioepiLiraglutide biosimilarAflibercept biosimilarFormycon ravegzaNovo holdings

Pearce IP BioBlast w/e 26 Jan 2024

AbbVie announced it will invest US$233M in its biologics manufacturing facility in Singapore. The investment will add 24,000L of biologics…

United kingdomSouth koreaUnited statesBayer eyleaSamsung biologicsGenentech avastinSamsung bioepi onbevziCoheru cimerliAlexion solirisGenentech lucentisSamsung bioepisRanibizumab biosimilarRegeneron sanofi dupixentSamsung bioepi episcliCoherus bioscience cimerliChinese national medical products administration

BioBlast f/e 16 Jun 23

BioBlast f/e 16 Jun 23
lexology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lexology.com Daily Mail and Mail on Sunday newspapers.

West virginiaUnited statesUnited kingdomSouth koreaNew zealandGenentech columviSamsung bioepisRegeneron eyleaGenentech ocrevusAmgen bekemvAbbvie humiraGenentech actemraGenentech herceptinJanssen remicadeAlexion solirisMark cuban

BioBlast w/e 24 Feb 23: Abbvie in hot water over Humira® pricing, Celltrion s Yuflyma® delays explained, Merck/Moderna mRNA vaccine/ Keytruda treatment, French Court overturns Novartis/Roche €444M cartel fine, Amgen s Amjevita® savings, Genetech new biologics facility, Regeneron new aflibercept product, Amgen s Bekemv® eculizumab

The Financial Times has reported that the Dutch Pharmaceutical Accountability Foundation (PAF), a public interest group, is suing AbbVie for…

United statesFrance generalSouth koreaRoche genentechAmgen amjevitaSamsung bioepis merckEli lilyAmgen bekemvFresenius kabiMylan viatrisRegeneron eyleaAbbvie humiraCelltrion yuflymaNovartis rocheAlexion solirisBoehringer ingelheim

One Year Post-Launch of Argenx s Vyvgart for gMG, US Neurologists Confused on Best Approach to Treatment Dosing Schedules, According to Spherix Global Insights

One Year Post-Launch of Argenx s Vyvgart for gMG, US Neurologists Confused on Best Approach to Treatment Dosing Schedules, According to Spherix Global Insights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Prnewswire argenxAlexion solirisGemma mcfaddenScott uphamGenentech enspryngCorporate communicationsSpherix networkSpherix global insightsLaunch dynamixMarket dynamixRealworld dynamixWorld dynamixGlobal insightsSenior insights directorSpherix global insight